This video is the fifth in a five-part series that focuses on making sense of multiple myeloma treatment based upon the newly obtained input from the American Society of Hematology (ASH) in Orlando, FL.
Download Slides
Topics include:
- Smoldering Myeloma
- Frontline Therapy
- Significance of FiSH testing
- CAR T therapy/Bi-specific T Cell engagers/MoAb
- Novel agents/combinations
with an educational grant from:
Amgen Oncology, Takeda Oncology, Janssen Oncology
